Inflammatory bowel disease and the risk of cardiovascular diseases. 2021

Paulina Nuñez, and Sandra García Mateo, and Rodrigo Quera, and Fernando Gomollón
Universidad de Chile, Hospital San Juan de Dios, Sección de Gastroenterología, Santiago, Chile.

Inflammatory bowel disease (IBD) includes both ulcerative colitis and Crohn's disease, which are well recognised as chronic systemic and immune-mediated conditions that frequently involve extraintestinal manifestations. Although comorbidities have long been the subject of research in other chronic inflammatory diseases, this concept is also emerging in IBD. Many pathologies have been linked to IBD, including cardiovascular disease, which is the main cause of death in developed countries. IBD patients are at increased risk of conditions such as early atherosclerosis and myocardial infarction or venous thrombosis and pulmonary thromboembolism. The aim of this review is to make an approximation of the physiopathology of the different manifestations of cardiovascular disease in patients with IBD and how to prevent them.

UI MeSH Term Description Entries
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015212 Inflammatory Bowel Diseases Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS. Bowel Diseases, Inflammatory,Inflammatory Bowel Disease
D018570 Risk Assessment The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988) Assessment, Risk,Benefit-Risk Assessment,Risk Analysis,Risk-Benefit Assessment,Health Risk Assessment,Risks and Benefits,Analysis, Risk,Assessment, Benefit-Risk,Assessment, Health Risk,Assessment, Risk-Benefit,Benefit Risk Assessment,Benefit-Risk Assessments,Benefits and Risks,Health Risk Assessments,Risk Analyses,Risk Assessment, Health,Risk Assessments,Risk Benefit Assessment,Risk-Benefit Assessments

Related Publications

Paulina Nuñez, and Sandra García Mateo, and Rodrigo Quera, and Fernando Gomollón
December 2022, The American journal of medicine,
Paulina Nuñez, and Sandra García Mateo, and Rodrigo Quera, and Fernando Gomollón
December 2019, Presse medicale (Paris, France : 1983),
Paulina Nuñez, and Sandra García Mateo, and Rodrigo Quera, and Fernando Gomollón
January 2023, Crohn's & colitis 360,
Paulina Nuñez, and Sandra García Mateo, and Rodrigo Quera, and Fernando Gomollón
August 2023, Inflammatory bowel diseases,
Paulina Nuñez, and Sandra García Mateo, and Rodrigo Quera, and Fernando Gomollón
February 2017, Experimental and therapeutic medicine,
Paulina Nuñez, and Sandra García Mateo, and Rodrigo Quera, and Fernando Gomollón
August 2014, World journal of gastrointestinal pathophysiology,
Paulina Nuñez, and Sandra García Mateo, and Rodrigo Quera, and Fernando Gomollón
December 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
Paulina Nuñez, and Sandra García Mateo, and Rodrigo Quera, and Fernando Gomollón
February 2016, Journal of Crohn's & colitis,
Paulina Nuñez, and Sandra García Mateo, and Rodrigo Quera, and Fernando Gomollón
January 2022, European heart journal open,
Paulina Nuñez, and Sandra García Mateo, and Rodrigo Quera, and Fernando Gomollón
November 2020, Clinical and experimental medicine,
Copied contents to your clipboard!